25 XP   0   0   10

Opthea Ltd
Buy, Hold or Sell?

Let's analyse Opthea together

PenkeI guess you are interested in Opthea Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Opthea Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Opthea Ltd

I send you an email if I find something interesting about Opthea Ltd.

Quick analysis of Opthea (30 sec.)










What can you expect buying and holding a share of Opthea? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$-0.01
Expected worth in 1 year
A$-0.49
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.47
Return On Investment
-75.9%

For what price can you sell your share?

Current Price per Share
A$0.63
Expected price per share
A$0.59 - A$0.8295
How sure are you?
50%

1. Valuation of Opthea (5 min.)




Live pricePrice per Share (EOD)

A$0.63

Intrinsic Value Per Share

A$-4.42 - A$-1.69

Total Value Per Share

A$-4.44 - A$-1.71

2. Growth of Opthea (5 min.)




Is Opthea growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.7m$45.3m-$51m-893.5%

How much money is Opthea making?

Current yearPrevious yearGrowGrow %
Making money-$137.7m-$83.1m-$54.5m-39.6%
Net Profit Margin-131,469.8%-102,353.7%--

How much money comes from the company's main activities?

3. Financial Health of Opthea (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#914 / 1010

Most Revenue
#647 / 1010

Most Profit
#963 / 1010

Most Efficient
#996 / 1010

What can you expect buying and holding a share of Opthea? (5 min.)

Welcome investor! Opthea's management wants to use your money to grow the business. In return you get a share of Opthea.

What can you expect buying and holding a share of Opthea?

First you should know what it really means to hold a share of Opthea. And how you can make/lose money.

Speculation

The Price per Share of Opthea is A$0.625. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opthea.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opthea, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$-0.01. Based on the TTM, the Book Value Change Per Share is A$-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opthea.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.14-22.4%-0.14-22.4%-0.09-14.6%-0.06-10.0%-0.04-5.6%
Usd Book Value Change Per Share-0.08-12.3%-0.08-12.3%-0.11-17.3%-0.01-1.2%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-12.3%-0.08-12.3%-0.11-17.3%-0.01-1.2%0.00-0.3%
Usd Price Per Share0.36-0.36-0.71-0.78-0.53-
Price to Earnings Ratio-2.56--2.56--7.86--29.16--35.17-
Price-to-Total Gains Ratio-4.64--4.64--6.60--7.66--12.80-
Price to Book Ratio-41.46--41.46-10.45-3.68-9.22-
Price-to-Total Gains Ratio-4.64--4.64--6.60--7.66--12.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4061875
Number of shares2461
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.08-0.01
Usd Total Gains Per Share-0.08-0.01
Gains per Quarter (2461 shares)-189.58-17.78
Gains per Year (2461 shares)-758.31-71.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-758-7680-71-81
20-1517-15260-142-152
30-2275-22840-213-223
40-3033-30420-284-294
50-3792-38000-356-365
60-4550-45580-427-436
70-5308-53160-498-507
80-6067-60740-569-578
90-6825-68320-640-649
100-7583-75900-711-720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%5.028.00.015.2%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%17.016.00.051.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.029.012.1%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%18.015.00.054.5%

Fundamentals of Opthea

About Opthea Ltd

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead product candidate is Sozinibercept (OPT 302), a soluble form of vascular endothelial growth factor receptor-3 "VEGFR-3", currently under Phase 3 clinical development as a novel therapy for wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Fundamental data was last updated by Penke on 2024-04-11 17:04:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Opthea Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Opthea earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • A Net Profit Margin of -131,469.8% means that $-1,314.70 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Opthea Ltd:

  • The MRQ is -131,469.8%. The company is making a huge loss. -2
  • The TTM is -131,469.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-131,469.8%TTM-131,469.8%0.0%
TTM-131,469.8%YOY-102,353.7%-29,116.1%
TTM-131,469.8%5Y-65,620.1%-65,849.7%
5Y-65,620.1%10Y-33,156.1%-32,464.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-131,469.8%-207.2%-131,262.6%
TTM-131,469.8%-216.8%-131,253.0%
YOY-102,353.7%-282.3%-102,071.4%
5Y-65,620.1%-436.8%-65,183.3%
10Y-33,156.1%-597.3%-32,558.8%
1.1.2. Return on Assets

Shows how efficient Opthea is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • -143.0% Return on Assets means that Opthea generated $-1.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Opthea Ltd:

  • The MRQ is -143.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -143.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-143.0%TTM-143.0%0.0%
TTM-143.0%YOY-146.6%+3.6%
TTM-143.0%5Y-80.2%-62.8%
5Y-80.2%10Y-54.1%-26.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-143.0%-13.3%-129.7%
TTM-143.0%-12.8%-130.2%
YOY-146.6%-11.6%-135.0%
5Y-80.2%-13.8%-66.4%
10Y-54.1%-15.6%-38.5%
1.1.3. Return on Equity

Shows how efficient Opthea is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • 0.0% Return on Equity means Opthea generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Opthea Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-183.4%+183.4%
TTM-5Y-62.0%+62.0%
5Y-62.0%10Y-47.6%-14.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-183.4%-14.9%-168.5%
5Y-62.0%-19.3%-42.7%
10Y-47.6%-20.1%-27.5%

1.2. Operating Efficiency of Opthea Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Opthea is operating .

  • Measures how much profit Opthea makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • An Operating Margin of -138,648.0% means the company generated $-1,386.48  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Opthea Ltd:

  • The MRQ is -138,648.0%. The company is operating very inefficient. -2
  • The TTM is -138,648.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-138,648.0%TTM-138,648.0%0.0%
TTM-138,648.0%YOY-106,576.0%-32,072.0%
TTM-138,648.0%5Y-69,720.3%-68,927.7%
5Y-69,720.3%10Y-35,403.6%-34,316.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-138,648.0%-298.0%-138,350.0%
TTM-138,648.0%-238.5%-138,409.5%
YOY-106,576.0%-288.4%-106,287.6%
5Y-69,720.3%-486.2%-69,234.1%
10Y-35,403.6%-628.4%-34,775.2%
1.2.2. Operating Ratio

Measures how efficient Opthea is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1,388.10 means that the operating costs are $1,388.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Opthea Ltd:

  • The MRQ is 1,388.100. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1,388.100. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1,388.100TTM1,388.1000.000
TTM1,388.100YOY1,067.755+320.346
TTM1,388.1005Y700.141+687.959
5Y700.14110Y355.829+344.311
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,388.1003.235+1,384.865
TTM1,388.1003.310+1,384.790
YOY1,067.7553.838+1,063.917
5Y700.1415.679+694.462
10Y355.8297.823+348.006

1.3. Liquidity of Opthea Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Opthea is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.25 means the company has $5.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Opthea Ltd:

  • The MRQ is 5.249. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.249. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.249TTM5.2490.000
TTM5.249YOY4.975+0.274
TTM5.2495Y14.131-8.882
5Y14.13110Y12.771+1.360
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2493.863+1.386
TTM5.2494.169+1.080
YOY4.9755.337-0.362
5Y14.1316.122+8.009
10Y12.7716.434+6.337
1.3.2. Quick Ratio

Measures if Opthea is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • A Quick Ratio of 5.11 means the company can pay off $5.11 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Opthea Ltd:

  • The MRQ is 5.109. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.109. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.109TTM5.1090.000
TTM5.109YOY4.251+0.858
TTM5.1095Y12.556-7.447
5Y12.55610Y11.324+1.232
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1093.504+1.605
TTM5.1093.991+1.118
YOY4.2515.371-1.120
5Y12.5566.088+6.468
10Y11.3246.395+4.929

1.4. Solvency of Opthea Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Opthea assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opthea to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.06 means that Opthea assets are financed with 105.9% credit (debt) and the remaining percentage (100% - 105.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Opthea Ltd:

  • The MRQ is 1.059. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.059. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.059TTM1.0590.000
TTM1.059YOY0.201+0.858
TTM1.0595Y0.311+0.748
5Y0.31110Y0.214+0.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0590.339+0.720
TTM1.0590.337+0.722
YOY0.2010.271-0.070
5Y0.3110.368-0.057
10Y0.2140.388-0.174
1.4.2. Debt to Equity Ratio

Measures if Opthea is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opthea to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Opthea Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.252-0.252
TTM-5Y0.119-0.119
5Y0.11910Y0.130-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY0.2520.335-0.083
5Y0.1190.427-0.308
10Y0.1300.461-0.331

2. Market Valuation of Opthea Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Opthea generates.

  • Above 15 is considered overpriced but always compare Opthea to the Biotechnology industry mean.
  • A PE ratio of -2.56 means the investor is paying $-2.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Opthea Ltd:

  • The EOD is -2.907. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.558. Based on the earnings, the company is expensive. -2
  • The TTM is -2.558. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.907MRQ-2.558-0.349
MRQ-2.558TTM-2.5580.000
TTM-2.558YOY-7.855+5.297
TTM-2.5585Y-29.160+26.602
5Y-29.16010Y-35.167+6.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.907-2.300-0.607
MRQ-2.558-2.656+0.098
TTM-2.558-2.718+0.160
YOY-7.855-4.145-3.710
5Y-29.160-6.258-22.902
10Y-35.167-6.315-28.852
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Opthea Ltd:

  • The EOD is -2.310. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.033. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.033. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.310MRQ-2.033-0.277
MRQ-2.033TTM-2.0330.000
TTM-2.033YOY-7.410+5.377
TTM-2.0335Y-45.619+43.586
5Y-45.61910Y-47.028+1.409
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.310-2.974+0.664
MRQ-2.033-3.306+1.273
TTM-2.033-3.508+1.475
YOY-7.410-5.613-1.797
5Y-45.619-8.378-37.241
10Y-47.028-8.873-38.155
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Opthea is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -41.46 means the investor is paying $-41.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Opthea Ltd:

  • The EOD is -47.111. Based on the equity, the company is expensive. -2
  • The MRQ is -41.458. Based on the equity, the company is expensive. -2
  • The TTM is -41.458. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-47.111MRQ-41.458-5.653
MRQ-41.458TTM-41.4580.000
TTM-41.458YOY10.450-51.908
TTM-41.4585Y3.683-45.141
5Y3.68310Y9.215-5.532
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-47.1111.914-49.025
MRQ-41.4582.116-43.574
TTM-41.4582.097-43.555
YOY10.4502.881+7.569
5Y3.6833.550+0.133
10Y9.2153.936+5.279
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Opthea Ltd.

3.1. Funds holding Opthea Ltd

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Opthea Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.119-0.1190%-0.167+41%-0.011-91%-0.003-97%
Book Value Per Share---0.013-0.0130%0.105-113%0.099-113%0.066-120%
Current Ratio--5.2495.2490%4.975+6%14.131-63%12.771-59%
Debt To Asset Ratio--1.0591.0590%0.201+427%0.311+241%0.214+395%
Debt To Equity Ratio----0%0.252-100%0.119-100%0.130-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.215-0.2150%-0.140-35%-0.096-55%-0.054-75%
Free Cash Flow Per Share---0.271-0.2710%-0.148-45%-0.110-59%-0.061-77%
Free Cash Flow To Equity Per Share--0.1050.1050%-0.148+242%0.030+250%0.021+410%
Gross Profit Margin--1.1071.1070%1.067+4%1.070+3%1.082+2%
Intrinsic Value_10Y_max---1.695--------
Intrinsic Value_10Y_min---4.424--------
Intrinsic Value_1Y_max---0.085--------
Intrinsic Value_1Y_min---0.242--------
Intrinsic Value_3Y_max---0.319--------
Intrinsic Value_3Y_min---0.905--------
Intrinsic Value_5Y_max---0.632--------
Intrinsic Value_5Y_min---1.760--------
Market Cap414254360.000+12%364543836.800364543836.8000%729087673.600-50%797356792.128-54%540850492.416-33%
Net Profit Margin---1314.698-1314.6980%-1023.537-22%-656.201-50%-331.561-75%
Operating Margin---1386.480-1386.4800%-1065.760-23%-697.203-50%-354.036-74%
Operating Ratio--1388.1001388.1000%1067.755+30%700.141+98%355.829+290%
Pb Ratio-47.111-14%-41.458-41.4580%10.450-497%3.683-1226%9.215-550%
Pe Ratio-2.907-14%-2.558-2.5580%-7.855+207%-29.160+1040%-35.167+1275%
Price Per Share0.625+12%0.5500.5500%1.100-50%1.203-54%0.816-33%
Price To Free Cash Flow Ratio-2.310-14%-2.033-2.0330%-7.410+265%-45.619+2144%-47.028+2214%
Price To Total Gains Ratio-5.273-14%-4.640-4.6400%-6.602+42%-7.659+65%-12.802+176%
Quick Ratio--5.1095.1090%4.251+20%12.556-59%11.324-55%
Return On Assets---1.430-1.4300%-1.466+3%-0.802-44%-0.541-62%
Return On Equity----0%-1.8340%-0.6200%-0.4760%
Total Gains Per Share---0.119-0.1190%-0.167+41%-0.011-91%-0.003-97%
Usd Book Value---5714685.082-5714685.0820%45343337.129-113%42604808.435-113%28297122.912-120%
Usd Book Value Change Per Share---0.077-0.0770%-0.108+41%-0.007-91%-0.002-97%
Usd Book Value Per Share---0.009-0.0090%0.068-113%0.064-113%0.043-120%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.140-0.1400%-0.091-35%-0.062-55%-0.035-75%
Usd Free Cash Flow---116550811.497-116550811.4970%-63943932.658-45%-47383211.042-59%-26228323.407-77%
Usd Free Cash Flow Per Share---0.176-0.1760%-0.096-45%-0.071-59%-0.040-77%
Usd Free Cash Flow To Equity Per Share--0.0680.0680%-0.096+242%0.019+250%0.013+410%
Usd Market Cap269223908.564+12%236917039.536236917039.5360%473834079.073-50%518202179.204-54%351498735.021-33%
Usd Price Per Share0.406+12%0.3570.3570%0.715-50%0.782-54%0.530-33%
Usd Profit---137701253.932-137701253.9320%-83180840.079-40%-56129565.663-59%-30006132.944-78%
Usd Revenue--104739.834104739.8340%81268.045+29%81149.893+29%314350.001-67%
Usd Total Gains Per Share---0.077-0.0770%-0.108+41%-0.007-91%-0.002-97%
 EOD+6 -2MRQTTM+0 -0YOY+15 -185Y+8 -2510Y+7 -26

4.2. Fundamental Score

Let's check the fundamental score of Opthea Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.907
Price to Book Ratio (EOD)Between0-1-47.111
Net Profit Margin (MRQ)Greater than0-1,314.698
Operating Margin (MRQ)Greater than0-1,386.480
Quick Ratio (MRQ)Greater than15.109
Current Ratio (MRQ)Greater than15.249
Debt to Asset Ratio (MRQ)Less than11.059
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.430
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Opthea Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.665
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Stockholder Equity 21,79443,01464,808115,393180,201-110,43169,770-78,563-8,793
Net Tangible Assets  31,12033,68964,80870,478135,286-87,30947,977-53,830-5,853
Net Invested Capital  31,12033,68964,80870,478135,286-87,30947,977-53,736-5,759
Net Interest Income  756-34721-349372-137235-10,470-10,235



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets148,188
Total Liabilities156,981
Total Stockholder Equity-8,793
 As reported
Total Liabilities 156,981
Total Stockholder Equity+ -8,793
Total Assets = 148,188

Assets

Total Assets148,188
Total Current Assets147,805
Long-term Assets383
Total Current Assets
Cash And Cash Equivalents 133,987
Net Receivables 9,859
Inventory 0
Other Current Assets 3,958
Total Current Assets  (as reported)147,805
Total Current Assets  (calculated)147,805
+/-0
Long-term Assets
Property Plant Equipment 303
Long-term Assets Other 80
Long-term Assets  (as reported)383
Long-term Assets  (calculated)383
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities28,157
Long-term Liabilities128,824
Total Stockholder Equity-8,793
Total Current Liabilities
Short-term Debt 146
Accounts payable 26,805
Other Current Liabilities 1,132
Total Current Liabilities  (as reported)28,157
Total Current Liabilities  (calculated)28,083
+/- 73
Long-term Liabilities
Long term Debt Total 85,744
Capital Lease Obligations Min Short Term Debt35
Long-term Liabilities Other 85,660
Long-term Liabilities  (as reported)128,824
Long-term Liabilities  (calculated)171,439
+/- 42,615
Total Stockholder Equity
Common Stock482,060
Retained Earnings -540,017
Accumulated Other Comprehensive Income 49,164
Other Stockholders Equity 0
Total Stockholder Equity (as reported)-8,793
Total Stockholder Equity (calculated)-8,793
+/-0
Other
Capital Stock320,884
Cash And Equivalents77,122
Cash and Short Term Investments 133,987
Common Stock Shares Outstanding 469,557
Current Deferred Revenue73
Liabilities and Stockholders Equity 148,188
Net Debt -133,714
Net Invested Capital -5,759
Net Tangible Assets -5,853
Net Working Capital 79,738
Property Plant and Equipment Gross 201
Short Long Term Debt Total 273



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
3,286
1,930
1,755
2,258
2,467
2,917
3,018
4,990
5,491
4,491
7,298
25,487
47,749
41,720
24,833
29,464
32,917
43,787
56,708
51,523
33,314
29,464
26,187
23,134
14,978
11,732
18,464
12,735
43,452
33,847
26,375
71,887
184,361
87,322
148,188
148,18887,322184,36171,88726,37533,84743,45212,73518,46411,73214,97823,13426,18729,46433,31451,52356,70843,78732,91729,46424,83341,72047,74925,4877,2984,4915,4914,9903,0182,9172,4672,2581,7551,9303,286
   > Total Current Assets 
1,824
471
301
811
825
908
911
2,831
3,170
2,196
5,063
14,398
25,890
20,223
10,054
12,457
19,163
21,118
41,317
45,041
31,817
27,438
23,933
18,595
12,294
9,397
16,814
12,431
42,520
33,213
25,837
71,317
183,973
87,121
147,805
147,80587,121183,97371,31725,83733,21342,52012,43116,8149,39712,29418,59523,93327,43831,81745,04141,31721,11819,16312,45710,05420,22325,89014,3985,0632,1963,1702,8319119088258113014711,824
       Cash And Cash Equivalents 
1,215
386
200
520
680
883
855
2,762
2,757
1,986
110
460
25,412
20,005
9,892
12,187
18,818
10,839
40,876
44,218
31,343
27,073
23,624
16,824
10,042
6,743
14,140
10,818
39,929
23,882
15,082
62,020
157,433
64,904
133,987
133,98764,904157,43362,02015,08223,88239,92910,81814,1406,74310,04216,82423,62427,07331,34344,21840,87610,83918,81812,1879,89220,00525,4124601101,9862,7572,7628558836805202003861,215
       Short-term Investments 
530
61
92
206
124
0
0
0
0
0
4,918
13,800
201
128
47
28
14
9,898
12
0
0
0
0
0
0
0
0
126
0
0
0
0
0
0
0
000000012600000000129,89814284712820113,8004,918000001242069261530
       Net Receivables 
79
24
9
85
21
25
56
69
413
210
35
113
252
57
64
62
181
83
266
514
383
304
223
1,695
332
390
180
165
391
289
207
8,818
7,377
9,535
9,859
9,8599,5357,3778,8182072893911651803903321,6952233043835142668318162645725211335210413695625218592479
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
25
24
33
52
180
150
298
163
309
91
61
86
76
1,920
2,264
2,494
1,321
2,201
9,042
10,548
479
19,162
12,681
3,958
3,95812,68119,16247910,5489,0422,2011,3212,4942,2641,920768661913091632981501805233242500000000000
   > Long-term Assets 
1,462
1,459
1,454
1,447
1,642
2,009
2,107
2,159
2,320
2,295
2,235
11,089
21,860
21,497
14,778
17,007
13,754
22,669
15,391
6,483
1,497
2,026
2,254
4,539
2,683
2,335
1,650
304
931
634
538
571
388
201
383
3832013885715386349313041,6502,3352,6834,5392,2542,0261,4976,48315,39122,66913,75417,00714,77821,49721,86011,0892,2352,2952,3202,1592,1072,0091,6421,4471,4541,4591,462
       Property Plant Equipment 
3
2
1
0
0
9
10
15
114
94
82
85
104
79
49
35
29
33
69
76
54
46
104
109
75
140
85
68
49
51
38
281
156
41
303
303411562813851496885140751091044654766933293549791048582941141510900123
       Goodwill 
15
14
12
11
9
8
7
49
38
27
16
0
0
0
0
0
149
111
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000111149000001627384978911121415
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,275
2,041
316
1,148
793
714
290
0
0
0
0002907147931,1483162,0412,2750000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
38
27
16,017
0
0
0
0
0
195
149
0
0
0
0
0
512
456
0
0
0
0
0
0
0
0
0
0
0000000000456512000001491950000016,017273800000000
       Long-term Assets Other 
1,444
1,443
1,441
1,436
1,633
1,992
2,090
2,095
2,169
1,807
1,774
10,347
21,003
25,513
367
381
0
0
0
0
0
0
0
0
0
0
0
0
0
862
768
0
232
160
80
801602320768862000000000000038136725,51321,00310,3471,7741,8072,1692,0952,0901,9921,6331,4361,4411,4431,444
> Total Liabilities 
46
32
38
52
32
44
97
121
167
162
142
365
325
371
318
312
4,289
1,720
4,998
2,339
2,022
2,421
2,862
2,464
1,874
1,866
1,803
1,549
1,577
5,806
4,581
7,079
4,160
17,552
156,981
156,98117,5524,1607,0794,5815,8061,5771,5491,8031,8661,8742,4642,8622,4212,0222,3394,9981,7204,28931231837132536514216216712197443252383246
   > Total Current Liabilities 
46
32
38
52
32
44
93
114
164
154
92
292
194
190
306
302
4,270
974
2,634
1,709
1,882
2,259
2,603
2,175
1,743
1,662
1,724
1,503
1,539
5,777
4,563
6,919
4,138
17,511
28,157
28,15717,5114,1386,9194,5635,7771,5391,5031,7241,6621,7432,1752,6032,2591,8821,7092,6349744,2703023061901942929215416411493443252383246
       Short-term Debt 
530
61
92
206
124
0
0
0
0
0
4,918
13,800
201
128
69
40
3,812
13,338
14
0
0
0
0
0
0
0
0
169
0
0
0
145
150
0
146
1460150145000169000000001413,3383,812406912820113,8004,918000001242069261530
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
244
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,584
1,556
5,306
4,129
5,838
3,220
16,581
26,805
26,80516,5813,2205,8384,1295,3061,5561,58400000000000000024400000000000
       Other Current Liabilities 
-484
-29
-54
-154
-92
44
93
114
53
67
-63,993
-13,751
-135
-22
204
212
246
404
791
396
475
460
470
458
518
413
409
320
343
471
434
879
655
930
1,132
1,132930655879434471343320409413518458470460475396791404246212204-22-135-13,751-63,99367531149344-92-154-54-29-484
   > Long-term Liabilities 
0
0
0
0
0
0
4
7
3
8
50
73
131
182
12
10
19
746
2,365
630
141
161
259
289
130
204
79
46
38
29
17
160
23
41
128,824
128,824412316017293846792041302892591611416302,36574619101218213173508374000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120
0
0
85,744
85,744001200000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
73
131
182
18
15
25
36
29
10
21
35
53
106
65
161
103
62
50
39
25
40
17
28
8
828174025395062103161651065335211029362515181821317300000000000
> Total Stockholder Equity
3,240
1,898
1,717
2,206
2,435
2,873
2,921
4,863
5,324
4,329
7,156
25,122
46,977
41,348
24,514
29,151
28,520
41,993
47,367
45,374
31,272
27,043
23,325
19,354
12,276
8,977
16,033
11,185
41,874
28,041
21,794
64,808
180,201
69,770
-8,793
-8,79369,770180,20164,80821,79428,04141,87411,18516,0338,97712,27619,35423,32527,04331,27245,37447,36741,99328,52029,15124,51441,34846,97725,1227,1564,3295,3244,8632,9212,8732,4352,2061,7171,8983,240
   Common Stock
2,238
1,806
1,806
2,181
2,396
2,496
2,558
2,808
2,948
3,058
10,719
26,805
50,230
50,345
32,939
33,836
25,290
24,612
28,132
31,733
30,970
32,613
41,013
40,317
36,005
37,146
41,296
40,210
75,196
72,286
79,154
162,103
311,885
342,147
482,060
482,060342,147311,885162,10379,15472,28675,19640,21041,29637,14636,00540,31741,01332,61330,97031,73328,13224,61225,29033,83632,93950,34550,23026,80510,7193,0582,9482,8082,5582,4962,3962,1811,8061,8062,238
   Retained Earnings 
-52
-663
-844
-925
-1,436
-1,498
-2,200
-3,289
-4,687
-6,668
-4,298
-3,074
-4,645
-10,388
-9,362
-5,658
2,168
2,841
12,750
13,283
3,202
-2,534
-14,158
-14,828
-17,562
-21,880
-21,764
-31,406
-37,076
-47,859
-60,271
-102,589
-165,333
-315,482
-540,017
-540,017-315,482-165,333-102,589-60,271-47,859-37,076-31,406-21,764-21,880-17,562-14,828-14,158-2,5343,20213,28312,7502,8412,168-5,658-9,362-10,388-4,645-3,074-4,298-6,668-4,687-3,289-2,200-1,498-1,436-925-844-663-52
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
1,054
755
755
950
1,475
1,875
2,563
5,344
7,062
7,979
786
1,481
1,502
1,522
0
0
0
0
0
0
0
0
0
0
0
-6,679
-4,561
3,188
4,886
4,919
0
0
25,262
29,641
0
029,64125,262004,9194,8863,188-4,561-6,679000000000001,5221,5021,4817867,9797,0625,3442,5631,8751,4759507557551,054



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue161
Cost of Revenue-250
Gross Profit-89-89
 
Operating Income (+$)
Gross Profit-89
Operating Expense-223,460
Operating Income-223,449-223,549
 
Operating Expense (+$)
Research Development181,564
Selling General Administrative19,270
Selling And Marketing Expenses22,626
Operating Expense223,460223,460
 
Net Interest Income (+$)
Interest Income1,578
Interest Expense-20,014
Other Finance Cost-8,201
Net Interest Income-10,235
 
Pretax Income (+$)
Operating Income-223,449
Net Interest Income-10,235
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-220,691-226,207
EBIT - interestExpense = -243,463
-220,691
-191,867
Interest Expense20,014
Earnings Before Interest and Taxes (EBIT)-223,449-200,677
Earnings Before Interest and Taxes (EBITDA)-223,299
 
After tax Income (+$)
Income Before Tax-220,691
Tax Provision--5,926
Net Income From Continuing Ops-142,521-214,765
Net Income-211,881
Net Income Applicable To Common Shares-142,521
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses223,610
Total Other Income/Expenses Net2,75810,235
 

Technical Analysis of Opthea
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Opthea. The general trend of Opthea is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Opthea's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Opthea Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.815 < 0.8295 < 0.8295.

The bearish price targets are: 0.605 > 0.6 > 0.59.

Tweet this
Opthea Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Opthea Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Opthea Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Opthea Ltd.

Opthea Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOpthea Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Opthea Ltd. The current adx is .

Opthea Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Opthea Ltd.

Opthea Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Opthea Ltd.

Opthea Ltd Daily Relative Strength Index (RSI) ChartOpthea Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Opthea Ltd.

Opthea Ltd Daily Stochastic Oscillator ChartOpthea Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Opthea Ltd.

Opthea Ltd Daily Commodity Channel Index (CCI) ChartOpthea Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Opthea Ltd.

Opthea Ltd Daily Chande Momentum Oscillator (CMO) ChartOpthea Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Opthea Ltd.

Opthea Ltd Daily Williams %R ChartOpthea Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Opthea Ltd.

Opthea Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Opthea Ltd.

Opthea Ltd Daily Average True Range (ATR) ChartOpthea Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Opthea Ltd.

Opthea Ltd Daily On-Balance Volume (OBV) ChartOpthea Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Opthea Ltd.

Opthea Ltd Daily Money Flow Index (MFI) ChartOpthea Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Opthea Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Opthea Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Opthea Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.665
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Opthea with someone you think should read this too:
  • Are you bullish or bearish on Opthea? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Opthea? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Opthea Ltd

I send you an email if I find something interesting about Opthea Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Opthea Ltd.

Receive notifications about Opthea Ltd in your mailbox!